Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195216 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195591 |
TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195615 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195800 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195870 |
TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-08-27 | 2023-07-05 | 144747 |
TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-01 | 2023-07-05 | 176797 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2023-04-27 | 2023-07-05 | 190689 |
TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-16 | 2023-07-05 | 195189 |
TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195429 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195569 |
TEVA-IRBESARTAN | 75MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195588 |
TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-19 | 2023-07-05 | 195600 |
TEVA-IRBESARTAN | 300MG | TABLET TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195609 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195775 |
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195795 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195864 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2022-08-18 | 2023-07-05 | 167156 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-27 | 2023-07-05 | 190752 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |